GLP-1 agonists like semaglutide and tirzepatide can be used alongside biologics for conditions such as rheumatoid arthritis or psoriatic arthritis
doi: 10.1172/JCI146353 Summary Keywords GIP, GLP-1, tirzepatide, basal insulin, type 2 diabetes, obesity, body weight, hypoglycemia Citation Lisco G, De Tullio A, Disoteo O, De Geronimo V, Piazzolla G, De Pergola G, Giagulli VA, Jirillo E, Guastamacchia E, Sabb C and Triggiani V (2022) Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
Blum, patients see an average loss of well into the 20 percentile
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Mounjaro (tirzepatide) is a dual receptor agonist (GLP-1 and GIP)